Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

First China Approved Rituximab Biosimilar HLX01: Pharmacokinetics, Safety and Efficacy Comparison to Reference Rituximab in the Phase 3 Diffuse Large B-Cell Lymphoma Study

Blood (2019) 134 (Supplement_1): 2878.

https://doi.org/10.1182/blood-2019-130603

Published: 2019

Journal Articles

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Katie Zomorodi, PhD, Todd Dumas, PharmD, Seth Berry, PharmD, Curtis Johnston, PharmD, Mark Eller, PhD

Blood (2016) 128 (22): 1631.

https://doi.org/10.1182/blood.V128.22.1631.1631

Published: 2016

Journal Articles

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

Martin S. Tallman, Francesco Lo-Coco, Ashutosh Pathak

Blood (2016) 128 (22): 4034.

https://doi.org/10.1182/blood.V128.22.4034.4034

Published: 2016

Journal Articles

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Bingcheng Liu, MD, Ying Wang, MD, Chunlin Zhou, MDPhD, Hui Wei, MDPhD, Dong Lin, MDPhD, Wei Li, MD, Kaiqi Liu, Guangji Zhang, Shuning Wei, Yan Li, MD, Benfa Gong, Yuntao Liu, Yingchang Mi, MD PhD, Jianxiang Wang, MD

Blood (2015) 126 (23): 1301.

https://doi.org/10.1182/blood.V126.23.1301.1301

Published: 2015

Journal Articles

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Monica Galli, MD, Hila Magen, MD, Hermann Einsele, Manik Chatterjee, MD, Mariella Grasso, MD, Giorgina Specchia, Paola Barbieri, MD, David Paoletti, MS, Silvia Pace, MS, Ralph D Sanderson, PhD, Alessandro Rambaldi, MD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3246.

https://doi.org/10.1182/blood.V126.23.3246.3246

Published: 2015

Journal Articles

Population Pharmacokinetic Modeling and Simulation of Recombinant Single-Chain Factor VIII (r VIII-SingleChain) in Patients with Hemophilia a

Ying Zhang, PhD, Tharin Limsakun, PhD, Debra M. Bensen-Kennedy, MD, Alex Veldman, MD, Zhenling Yao, MD PhD

Blood (2014) 124 (21): 2814.

https://doi.org/10.1182/blood.V124.21.2814.2814

Published: 2014

Journal Articles

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Zartash Gul, MD, Qaiser Bashir, MD, Yago Nieto, M.D., Ph.D., Nazeer Sherwani, Simrit Parmar, M.D., Nina Shah, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Elizabeth J Shpall, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 2027.

https://doi.org/10.1182/blood.V120.21.2027.2027

Published: 2012

Journal Articles

Clinical Significance of Dose Reductions of Dasatanib and Nilotinib When Used As Frontline Therapy for Chronic Phase -Chronic Myeloid Leukemia (CML-CP) Does Not Affect Outcome,

Asifa Malik, MD, Hagop M. Kantarjian, Alfonso Quintas-Cardama, MD, Susan o'Brien, Srdan Verstovsek, MD, PhD, Gautam Borthakur, Farhad Ravandi, MD, Deborah A. Thomas, MD, Elizabeth M Burton, Elias Jabbour, Jorge E. Cortes

Blood (2011) 118 (21): 3786.

https://doi.org/10.1182/blood.V118.21.3786.3786

Published: 2011

Journal Articles

Bortezomib May Be Safely Combined with Y-90 Ibritumomab Tiuxetan In Patients with Relapsed/Refractory Follicular or Transformed Non-Hodgkin Lymphoma: A Phase I Trial of Combined Induction Therapy and Bortezomib Consolidation

Rupali Roy, M.D., Andrew M Evens, DO, MSc, David P. Patton, B.S., Annette Larsen, B.S., R.N., Alfred Rademaker, Ph.D., Jeffrey Cilley, M.D., Stewart Spies, M.D., Daina Variakojis, M.D., Leo I Gordon, M.D., Jane N. Winter, M.D.

Blood (2010) 116 (21): 1749.

https://doi.org/10.1182/blood.V116.21.1749.1749

Published: 2010

Journal Articles

Clinical Significance of Cardiac Co-Morbidities and Risk Factors for Patients Treated with Imatinib.

Asifa Malik, MD, Jorge E. Cortes, MD, Hagop Kantarjian, MD, Gloria Mattiuzzi, MD, Gloria Iliescu, MD, Alessandra Ferrajoli, MD, Gautam Borthakur, MD, Tapan Kadia, MD, Susan O'Brien

Blood (2010) 116 (21): 4490.

https://doi.org/10.1182/blood.V116.21.4490.4490

Published: 2010

Journal Articles

Comparison of Multiple Myeloma Donor Patient Samples and Derived Cell Lines Identifies a Confirmed Hyperdiploid Myeloma Cell Line and Demonstrates Remarkable Genetic Similarity Between Cell Lines and Patient Samples

Jonathan J Keats, PhD, Bonnie K. Arendt, Esteban Braggio, PhD, Michael Barrett, PhD, Tammy Price-Troska, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Diane F. Jelinek, PhD

Blood (2008) 112 (11): 2732.

https://doi.org/10.1182/blood.V112.11.2732.2732

Published: 2008

Journal Articles

Iron Sufficient to Cause Hepatic Fibrosis and Ascites Does Not Cause Cardiac Arrhythmias in the Gerbil

Lana Kaiser, MD, DVM, John Davis, BS, Jon Patterson, DVM, Abby Johnson, George Bohart, DVM, Kenneth A. Schwartz, MD

Blood (2008) 112 (11): 3834.

https://doi.org/10.1182/blood.V112.11.3834.3834

Published: 2008

Journal Articles

Anemia an Old Player or a Cut-Throat in Patients with Coronary Artery Disease or Chronic Heart Failure.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2007) 110 (11): 3762.

https://doi.org/10.1182/blood.V110.11.3762.3762

Published: 2007

Journal Articles

Zygomycosis: A Severe Fungal Infection with Challenging Diagnostic Difficulties: A Case with Cardiac Involvement without Cardiac Symptoms.

Maria I.A. Madeira, MD, Maria C. Favarin, MD, Leonardo C. Palma, MD, George M.N. Barros, MD, Cristina A. Souza, Clarisse M. Machado, PhD, MD, Julio C. Voltarelli, PhD, MD, Ana B.P.L. Stracieri, PhD, MD, Belinda P. Simoes, PhD, MD

Blood (2007) 110 (11): 5019.

https://doi.org/10.1182/blood.V110.11.5019.5019

Published: 2007

Journal Articles

Mobilization of Endothelial Progenitor Cells in Autologous and Allogeneic Peripheral Blood Stem Cell Grafts.

David Allan, MD, Pascale Dubé, MSc, Jean Roy, MD, Denis-Claude Roy, MD

Blood (2005) 106 (11): 4231.

https://doi.org/10.1182/blood.V106.11.4231.4231

Published: 2005

Journal Articles

Lysophosphatidic acid accelerates the development of human mast cells

Savita Bagga, Kursteen S. Price, Debby A. Lin, Daniel S. Friend, K. Frank Austen, Joshua A. Boyce

Blood (2004) 104 (13): 4080–4087.

https://doi.org/10.1182/blood-2004-03-1166

Published: 2004

Journal Articles

Utility of Holter Electrocardiogram Monitoring in Iron over Loaded β Thalassemia and Sickle Cell Disease.

Naveen Qureshi, MD, Kishor Avasarala, MD, Sylvia Titi Singer, MD, Drucilla Foote, PNP, Ekua Hackney-Stephens, PNP, Robert Hagar, MD, Elliott P. Vichinsky, MD

Blood (2004) 104 (11): 3784.

https://doi.org/10.1182/blood.V104.11.3784.3784

Published: 2004

Journal Articles

Retinoic acid controls blood vessel formation by modulating endothelial and mural cell interaction via suppression of Tie2 signaling in vascular progenitor cells

Yasuhiro Suzuki, Yusuke Komi, Hiromi Ashino, Jun Yamashita, Jun Inoue, Atsushi Yoshiki, Anne Eichmann, Hiroshi Amanuma, Soichi Kojima

Blood (2004) 104 (1): 166–169.

https://doi.org/10.1182/blood-2003-09-3293

Published: 2004

Journal Articles

Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage

Takami Yurugi-Kobayashi, Hiroshi Itoh, Jun Yamashita, Kenichi Yamahara, Hideyo Hirai, Takuya Kobayashi, Minetaro Ogawa, Satomi Nishikawa, Shin-Ichi Nishikawa, Kazuwa Nakao

Blood (2003) 101 (7): 2675–2678.

https://doi.org/10.1182/blood-2002-06-1877

Published: 2003

NARROW

First China Approved Rituximab Biosimilar HLX01: Pharmacokinetics, Safety and Efficacy Comparison to Reference Rituximab in the Phase 3 Diffuse Large B-Cell Lymphoma Study

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Population Pharmacokinetic Modeling and Simulation of Recombinant Single-Chain Factor VIII (r VIII-SingleChain) in Patients with Hemophilia a

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Clinical Significance of Dose Reductions of Dasatanib and Nilotinib When Used As Frontline Therapy for Chronic Phase -Chronic Myeloid Leukemia (CML-CP) Does Not Affect Outcome,

Bortezomib May Be Safely Combined with Y-90 Ibritumomab Tiuxetan In Patients with Relapsed/Refractory Follicular or Transformed Non-Hodgkin Lymphoma: A Phase I Trial of Combined Induction Therapy and Bortezomib Consolidation

Clinical Significance of Cardiac Co-Morbidities and Risk Factors for Patients Treated with Imatinib.

Comparison of Multiple Myeloma Donor Patient Samples and Derived Cell Lines Identifies a Confirmed Hyperdiploid Myeloma Cell Line and Demonstrates Remarkable Genetic Similarity Between Cell Lines and Patient Samples

Iron Sufficient to Cause Hepatic Fibrosis and Ascites Does Not Cause Cardiac Arrhythmias in the Gerbil

Anemia an Old Player or a Cut-Throat in Patients with Coronary Artery Disease or Chronic Heart Failure.

Zygomycosis: A Severe Fungal Infection with Challenging Diagnostic Difficulties: A Case with Cardiac Involvement without Cardiac Symptoms.

Mobilization of Endothelial Progenitor Cells in Autologous and Allogeneic Peripheral Blood Stem Cell Grafts.

Lysophosphatidic acid accelerates the development of human mast cells

Utility of Holter Electrocardiogram Monitoring in Iron over Loaded β Thalassemia and Sickle Cell Disease.

Retinoic acid controls blood vessel formation by modulating endothelial and mural cell interaction via suppression of Tie2 signaling in vascular progenitor cells

Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only